Content Block Tag: NRG-LU005: Small Cell Lung Cancer

‘Text/HTML’ of page ‘NRG-LU005: Small Cell Lung Cancer’

Frequently Asked Questions Below, you can find FAQs about clinical research and this particular clinical trial.

‘Text/HTML’ of page ‘NRG-LU005: Small Cell Lung Cancer’

Frequently Asked Questions Below, you can find FAQs about clinical research and this particular clinical trial.

‘Text/HTML’ of page ‘NRG-LU005: Small Cell Lung Cancer’

Quick Information Find a study location Are you interested in joining this study? Find a Participating Location Want more information? Additional information for the NRG Oncology LU005 trial can be found in the Patient Study Brochure Download Brochure Educational information on radiotherapy and lung cancer treatment can be found on this LUNGevity Foundation webpage.Visit the LUNGevity Website

‘Text/HTML’ of page ‘NRG-LU005: Small Cell Lung Cancer’

Am I eligible for this study? Your healthcare team is the best source for information about your treatment options, including the ability to help you make the decision to participate in cancer clinical trials. Be sure to take the information you find to your doctor for discussion about possible studies and for questions and concerns. […]

‘Text/HTML’ of page ‘NRG-LU005: Small Cell Lung Cancer’

About This Study This study is closed to patient enrollment because it has reached its recruitment goal! This will remain open to sites in Japan. NRG-LU005 was a National Cancer Institute and NRG Oncology clinical trial to study if adding the immunotherapy drug called atezolizumab to the usual treatment of chemoradiotherapy can help lower the chance of […]

‘Text/HTML’ of page ‘NRG-LU005: Small Cell Lung Cancer’

NRG-LU005 FAQ